STRUCTURAL HOMOLOGIES AMONG THROMBOXANE (TXA2) RECEPTOR ANTAGONISTS - MINIMAL PHARMACOPHORIC REQUIREMENTS FOR HIGH-AFFINITY INTERACTION WITH TXA2 RECEPTORS

被引：4

作者：

LADOUCEUR, G ^{[1
]}

MAIS, DE ^{[1
]}

JAKUBOWSKI, JA ^{[1
]}

UTTERBACK, BG ^{[1
]}

ROBERTSON, DW ^{[1
]}

机构：

[1] ELI LILLY & CO, LILLY RES LAB, DEPT CARDIOVASC PHARMACOL, INDIANAPOLIS, IN 46285 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1991年 / 1卷 / 03期

关键词：

(+/-)-(5Z)-7-<3-ENDO-<(PHENYLSULFONYL)AMINO>BICYCLO<2.2.1>HEPT-2-EXO-YL>HEPTENO; S-145;

D O I：

10.1016/S0960-894X(01)80794-0

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Several sulfonamide derivatives related to S-145 were synthesized and tested as thromboxane receptor antagonists. The results reveal the importance of the orientation between the sulfonamide moiety and the carboxyclic acid group of the alpha-side chain in order to obtain high affinity interaction with TXA2 receptors.

引用

页码：173 / 178

页数：6

共 50 条

[31] AN AFFINITY COLUMN FOR PURIFICATION OF THE HUMAN-PLATELET THROMBOXANE A2 PROSTAGLANDIN H2 (TXA2/PGH2) RECEPTOR
VENTON, DL
ARORA, SK
KIM, SO
LIM, CT
LEBRETON, GC
FEDERATION PROCEEDINGS, 1987, 46 (06) : 1943 - 1943
[32] Selective desensitization of the endothelial thromboxane A2(TxA2) receptor by protein kinase C (PKC) alpha
Yukawa, M
Eberhardt, RT
Yokota, R
vonAndrian, L
Ware, JA
CIRCULATION, 1996, 94 (08) : 3389 - 3389
[33] MODULATION OF AGONIST AFFINITY FOR THROMBOXANE A2(TXA2) RECEPTORS ON GUINEA-PIG LUNG MEMBRANES (GPLM) BY DIVALENT-CATIONS
SAUSSY, DL
FROELICH, LL
COOLEY, BA
MAIS, DE
FASEB JOURNAL, 1992, 6 (05): : A1860 - A1860
[34] PLATELET THROMBOXANE A2 ENDOPEROXIDE (TXA2/PGH2) RECEPTORS IN TYPE-1 DIABETES-MELLITUS
JASCHONEK, K
FAUL, C
WEISENBERGER, H
KRONERT, K
SCHRODER, H
RENN, W
THROMBOSIS AND HAEMOSTASIS, 1989, 61 (03) : 535 - 536
[35] PROSTACYCLIN (PGI2)- AND THROMBOXANE (TXA2/PGH2) RECEPTORS IN PLATELETS AND VESSEL WALL IN CONTROL CONDITIONS AND ISCHEMIA
JASCHONEK, K
HAEMOSTASIS, 1986, 16 : 43 - 43
[36] PKCα deficiency in mice is associated with pulmonary vascular hyperresponsiveness to thromboxane A2 via increased TXA2 receptor expression
Tabeling, Christoph
Noe, Elena
Naujoks, Jan
Doehn, Jan-Moritz
Hippenstiel, Stefan
Opitz, Bastian
Suttorp, Norbert
Klopfleisch, Robert
Witzenrath, Martin
EUROPEAN RESPIRATORY JOURNAL, 2014, 44
[37] FAILURE OF DOG PLATELETS TO RESPOND TO THROMBOXANE A2 (TXA2) IS DUE TO A DYSFUNCTIONAL RECEPTOR-LINKED G PROTEIN
JOHNSON, GJ
DUNLOP, PC
LEIS, LA
ARTERIOSCLEROSIS, 1988, 8 (05): : A716 - A716
[38] ANTAGONISM OF U46619-INDUCED AGGREGATION OF HUMAN AND CANINE PLATELETS BY 4 TXA2 RECEPTOR ANTAGONISTS
BUSH, LR
SMITH, SG
THROMBOSIS RESEARCH, 1986, 44 (03) : 377 - 389
[39] Synthesis and pharmacological evaluation of a series of N-substituted sulfonamide based TXA2 receptor antagonists.
Taylor, DM
Halushka, PV
Meier, GP
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U11 - U12
[40] MODIFICATION OF PLATELET-NEUTROPHIL INTERACTION BY SELECTIVE THROMBOXANE (TXA2) SYNTHETASE INHIBITOR U63,557A
MEHTA, P
MEHTA, J
WARD, MB
LAWSON, D
CLINICAL RESEARCH, 1987, 35 (03): : A601 - A601

← 1 2 3 4 5 →